Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

Cidara Therapeutics Inc (CDTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cidara Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.370 +0.820    +6.05%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
14.370
0.000
0.000%
18:59:20 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 66,110
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 13.820 - 14.545
Cidara Therapeutics Inc 14.370 +0.820 +6.05%

CDTX Overview

 
Cidara Therapeutics Inc stock price live, this page displays NASDAQ CDTX stock exchange data. View the CDTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cidara Therapeutics Inc real time stock price chart below.

What Is the Cidara Therapeutics Inc Stock Price Today?
The Cidara Therapeutics Inc stock price today is 14.370.

What Is the Stock Symbol for Cidara Therapeutics Inc?
The stock symbol for Cidara Therapeutics Inc is "CDTX."

What Stock Exchange Does Cidara Therapeutics Inc Trade On?
Cidara Therapeutics Inc is listed and trades on the NASDAQ stock exchange.

Is Cidara Therapeutics Inc a Good Stock to Buy?
Determining whether Cidara Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CDTX quote. (ISIN: US1717572069)
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close13.55
Day's Range13.82 - 14.545
Revenue46.26M
Open13.92
52 wk Range10.004 - 24.4
EPS - 7.88
Volume66,110
Market Cap64.78M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)72,231
P/E Ratio - 1.82
Beta1.11
1-Year Change - 40.13%
Shares Outstanding4,561,708
Next Earnings DateAug 08, 2024
What is your sentiment on Cidara Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Cidara Therapeutics Inc News


Candel Therapeutics to Join Russell 3000 Index
Candel Therapeutics to Join Russell 3000 Index By Investing.com - Jun 11, 2024

Candel Therapeutics, Inc. (Nasdaq: CADL) today announced that the Company is set to join the broad-market Russell 3000 Index at the conclusion of the 2024 Russell US Indexes annual...

Cidara Therapeutics Inc Analysis


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Sell
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Bullish doji Star 15 3 Jun 12, 2024 02:15PM
Doji Star Bearish 30 4 Jun 12, 2024 01:00PM
Gravestone Doji 30 4 Jun 12, 2024 01:00PM
Bullish Engulfing 1M 6 Dec 23
Morning Doji Star 1M 6 Dec 23

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from Watchlist  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 213.07 220.20 206.91 +5.92 +2.86% 197.59M  
  Tesla 177.19 180.55 169.80 +6.53 +3.83% 89.96M 16:00:00  
  Microsoft 441.06 443.40 433.25 +8.38 +1.94% 22.22M  
  NVIDIA 125.20 126.88 122.57 +4.29 +3.55% 270.39M 15:59:59  
  Meta Platforms 508.84 514.01 504.47 +1.37 +0.27% 11.36M 15:59:59  
  Amazon.com 186.89 188.35 185.44 -0.34 -0.18% 33.61M 15:59:59  
  Oracle 140.38 140.96 134.01 +16.50 +13.32% 40.78M 16:00:29  
  Alphabet A 177.79 180.41 176.11 +1.17 +0.66% 26.12M 15:59:59  
  Broadcom 1,495.51 1,505.79 1,476.40 +34.48 +2.36% 3.78M 15:59:59  
  AMD 160.24 162.23 158.62 +1.28 +0.81% 48.10M 15:59:59  

Cidara Therapeutics Inc Company Profile

IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

73

Equity Type

ORD

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Read More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CDTX Comments

Write your thoughts about Cidara Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dan DJ
Dan DJ Dec 18, 2020 6:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CDTX just registred a International Patent #2020252393 published today for "Compositions and methods for the treatment of HIV"
Jeff Brochetti
Jeff Brochetti Sep 19, 2019 9:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
mane this bout to be some fire
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email